Advertisement
Advertisement
ROIV
Roivant Sciences Ltd. Common Shares
29.96
USDSponsored
-0.92
-2.98%
May 22, 16:00 UTC -4
Closed
Pre-Market
30.14
+0.18
+0.60%
ROIV Earnings Reports
Positive Surprise Ratio
ROIV beat 9 of 19 last estimates.
47%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Roivant Sciences Ltd. Common Shares earnings per share and revenue
On May 20, 2026, ROIV reported earnings of -0.57 USD per share (EPS) for Q4 26, missing the estimate of -0.35 USD, resulting in a -64.63% surprise. Revenue reached 2.52 million, compared to an expected 3.90 million, with a -35.32% difference. The market reacted with a +14.89% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Belite Bio, Inc - ADR
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.64
Actual
-$0.68
Surprise
-4.87%
Immunovant, Inc. Common Stock
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.61
Actual
-$0.73
Surprise
-19.11%
Compugen Ltd
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.08
Surprise
-8.11%
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
Scilex Holding Company Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-Actual
-$4.76
Surprise
-
MiNK Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.78
Actual
-$0.56
Surprise
+27.43%
OS Therapies Incorporated
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.27
Surprise
-49.83%
Annovis Bio, Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.40
Actual
-$0.63
Surprise
-56.37%
Akari Therapeutics plc ADR (0.01 USD)
Report Date
May 19, 2026 For Q1 26
Estimate
-$1.40
Actual
-$1.57
Surprise
-11.81%
EVOGENE LTD.
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.60
Surprise
-117.86%
FAQ
What were Roivant Sciences Ltd. Common Shares's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Roivant Sciences Ltd. Common Shares reported EPS of -$0.57, missing estimates by -64.63%, and revenue of $2.52M, -35.32% below expectations.
How did the market react to Roivant Sciences Ltd. Common Shares's Q4 2026 earnings?
The stock price moved up 14.89%, changed from $28.21 before the earnings release to $32.41 the day after.
When is Roivant Sciences Ltd. Common Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Roivant Sciences Ltd. Common Shares's next earnings report?
Based on --
analysts, Roivant Sciences Ltd. Common Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement